| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 20, 2023 | TTOO T2 Biosystems, Inc. | Cr Group L.P. | 10% Owner | Sell | 7,753,710 | $0.31 | $2,408,302.33 | -20.4% | - | - | |
| Sep 19, 2023 | IQV Iqvia Holdings Inc. | Panagos Constantinos | See Remarks | Sell | 27,317 | $208.67 | $5,700,339.59 | -36.6% | +8.2% | +16.2% | |
| Sep 19, 2023 | TTOO T2 Biosystems, Inc. | Cr Group L.P. | 10% Owner | Sell | 10,401,466 | $0.37 | $3,806,936.56 | -21.5% | - | - | |
| Sep 19, 2023 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 190,764 | $263.89 | $50,339,893.74 | -1.5% | +17.8% | +41.3% | |
| Sep 19, 2023 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | - | Sell | 190,764 | $263.89 | $50,339,893.74 | -1.5% | +17.8% | +41.3% | |
| Sep 18, 2023 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 10,752 | $4.16 | $44,748.75 | -20.1% | -53.9% | +830.8% | |
| Sep 18, 2023 | WGS Genedx Holdings Corp. | Saad Kareem61 | Chief Transformation Officer | Sell | 1,580 | $4.16 | $6,575.49 | -8.1% | -53.9% | +830.8% | |
| Sep 18, 2023 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 2,742 | $4.16 | $11,409.46 | -14.0% | -53.9% | +830.8% | |
| Sep 14, 2023 | ISPC Ispecimen Inc. | Bielak Benjamin | Chief Info Officer &Secretary | Buy | 18,000 | $0.72 | $12,960.00 | +27.1% | -30.5% | -73.2% | |
| Sep 12, 2023 | GH Guardant Health, Inc. | Kalia Kumud61 | Chief Information Officer | Sell | 2,125 | $32.59 | $69,253.75 | -21.4% | -18.3% | -23.5% | |
| Sep 11, 2023 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 904 | $4.62 | $4,180.10 | -6.8% | -64.8% | +605.9% | |
| Sep 11, 2023 | WGS Genedx Holdings Corp. | Saad Kareem61 | Chief Transformation Officer | Sell | 846 | $4.62 | $3,911.90 | -5.5% | -64.8% | +605.9% | |
| Sep 11, 2023 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 2,675 | $4.62 | $12,369.20 | -7.2% | -64.8% | +605.9% | |
| Sep 8, 2023 | AWHL Aspira Women's Health Inc. | Hombeck Torsten | Chief Financial Officer | Buy | 2,246 | $4.30 | $9,657.80 | +297.9% | - | - | |
| Sep 7, 2023 | FLGT Fulgent Genetics, Inc. | Gao Hanlin73 | Chief Scientific Officer | Sell | 1,041 | $31.41 | $32,695.62 | -0.1% | -16.3% | -32.5% | |
| Sep 7, 2023 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 1,492 | $31.41 | $46,860.59 | -0.7% | -16.3% | -32.5% | |
| Sep 7, 2023 | FLGT Fulgent Genetics, Inc. | Xie Jian77 | President And COO | Sell | 1,492 | $31.41 | $46,860.59 | -0.4% | -16.3% | -32.5% | |
| Sep 6, 2023 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 6,000 | $59.10 | $354,592.25 | -0.6% | +0.5% | +102.6% | |
| Sep 5, 2023 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 2,819 | $9.49 | $26,762.18 | -0.6% | +8.0% | +202.8% | |
| Sep 5, 2023 | GH Guardant Health, Inc. | Joyce Meghan V.56 | Director | Sell | 100 | $35.01 | $3,501.00 | -2.3% | -23.7% | -31.0% | |
| Sep 5, 2023 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 269 | $4.38 | $1,178.14 | -2.4% | -60.2% | +577.8% | |
| Sep 1, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 1,500 | $20.05 | $30,078.00 | -0.4% | +1.7% | +50.9% | |
| Sep 1, 2023 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 1,802 | $20.04 | $36,112.08 | -0.8% | +1.7% | +50.9% | |
| Sep 1, 2023 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 10,000 | $60.01 | $600,062.00 | -2.0% | -10.5% | +89.2% | |
| Sep 1, 2023 | EXAS Exact Sciences Corp | Condella Sarah75 | EVP, Human Resources | Sell | 4,500 | $84.36 | $379,620.00 | -5.6% | -24.8% | -27.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.